Back to Trades
Lo Andrew
DirectorCIK 0001679076
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Lo Andrew, Director, accounts for 2 disclosed filings worth $6.7M, all concentrated in BridgeBio Pharma, Inc. (BBIO), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $6.3M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.